TYK2-KINASE-INHIBITOREN

European patent · EP3864009 · In force

Register entry

Publication number
EP3864009
Application number
EP19794095
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 7, 2019
Published
Aug 18, 2021
Granted
Feb 19, 2025
Protection ends at the latest
Oct 6, 2039
Next annual fee due
Oct 31, 2026
IPC classes
C07D 263/48 (2006.01)
A61P 29/00 (2006.01)
A61P 37/00 (2006.01)
A61K 31/541 (2006.01)
Priority
GB 201816369 08.10.2018
PCT application
PCT/EP2019/077118 07.10.2019
PCT publication
WO2020/074461 16.04.2020
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Dec 31, 2025

    Change

    Published in Swissreg on 31.12.2025

  2. Nov 1, 2025

    Change

    Published in Swissreg on 01.11.2025

  3. Feb 21, 2025

    Agent entered

    Representative
    MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex

    Published in Swissreg on 21.02.2025

  4. Feb 19, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 19.02.2025

Parties

Inventor

READER, John Charles

Cambridgeshire CB22 3FX, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.